Theraclion Past Earnings Performance

Past criteria checks 0/6

Theraclion's earnings have been declining at an average annual rate of -1.5%, while the Medical Equipment industry saw earnings growing at 14.5% annually. Revenues have been declining at an average rate of 11.9% per year.

Key information

-1.5%

Earnings growth rate

23.7%

EPS growth rate

Medical Equipment Industry Growth21.6%
Revenue growth rate-11.9%
Return on equity-108.5%
Net Margin-277.7%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

We Think Theraclion (EPA:ALTHE) Has A Fair Chunk Of Debt

Nov 20
We Think Theraclion (EPA:ALTHE) Has A Fair Chunk Of Debt

Does Theraclion (EPA:ALTHE) Have A Healthy Balance Sheet?

Nov 26
Does Theraclion (EPA:ALTHE) Have A Healthy Balance Sheet?

Revenue & Expenses Breakdown

How Theraclion makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ENXTPA:ALTHE Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 241-430
31 Mar 242-430
31 Dec 232-430
30 Sep 232-430
30 Jun 232-530
31 Mar 232-530
31 Dec 221-530
30 Sep 221-540
30 Jun 221-540
31 Mar 221-430
31 Dec 211-430
30 Sep 212-410
30 Jun 212-420
31 Mar 211-420
31 Dec 201-420
30 Sep 201-430
30 Jun 202-420
31 Mar 203-420
31 Dec 193-420
30 Sep 193-440
30 Jun 192-410
31 Mar 192-520
31 Dec 182-630
30 Sep 182-620
30 Jun 183-640
31 Mar 183-640
31 Dec 173-630
30 Sep 173-640
30 Jun 172-640
31 Mar 172-640
31 Dec 162-740
30 Sep 162-740
30 Jun 162-740
31 Mar 162-740
31 Dec 152-640
30 Sep 151-630
30 Jun 150-630
31 Mar 151-530
31 Dec 141-520
30 Sep 141-520
30 Jun 141-420
31 Mar 140-420
31 Dec 130-420

Quality Earnings: ALTHE is currently unprofitable.

Growing Profit Margin: ALTHE is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ALTHE is unprofitable, and losses have increased over the past 5 years at a rate of 1.5% per year.

Accelerating Growth: Unable to compare ALTHE's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ALTHE is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (12.5%).


Return on Equity

High ROE: ALTHE has a negative Return on Equity (-108.48%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 01:39
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Theraclion SA is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Fanny MeindreCIC Market Solutions (ESN)
Fanny MeindreCIC Market Solutions (ESN)
Martial DescouturesInvest Securities